Definitions

Ark. Code Ann. § 20-15-2103 — under Disease and Disease Prevention Generally.

Ark. Code Ann. § 20-15-2103

(1) As used in this subchapter:(1) “Eligible patient” means a person who meets the requirements of eligibility in § 20-15-2104;(2) “Investigational drug, biological product, or device” means a drug, biological product, or device that:(A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and(B) Remains currently under investigation in a United States Food and Drug Administration clinical trial;(3) “Physician” means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and(4) “Terminal illness” means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time.

(1) “Eligible patient” means a person who meets the requirements of eligibility in § 20-15-2104;

(2) “Investigational drug, biological product, or device” means a drug, biological product, or device that:(A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and(B) Remains currently under investigation in a United States Food and Drug Administration clinical trial;

(A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and

(B) Remains currently under investigation in a United States Food and Drug Administration clinical trial;

(3) “Physician” means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and

(4) “Terminal illness” means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time.